GT Metabolic Solutions has filed a notice of an exempt offering of securities to raise $20,223,000.00 in Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, GT Metabolic Solutions is raising $20,223,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Thierry Thaure played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About GT Metabolic Solutions
We are dedicated to revolutionizing gastric bypass. From the procedure to the recovery, our skilled team of engineers and surgeons are dedicated to providing effective solutions never before seen by the medical community. Innovations in laparoscopic and endoluminal technique at the end of the 20th century contributed to the more than ten-fold growth in metabolic/bariatric surgery (MBS) over the last twenty years. MBS procedures became markedly safer and more acceptable to patients. Even so, in 2022, MBS is vastly underutilized. Obesity and its associated diseases continue to generate a tidal wave of human suffering and unchecked health care costs. We all wish to halt this damaging trend. Minimally invasive approaches that further reduce operative risk and enhance MBS adoption are crucially needed. Magnetic surgery is such an approach. Magnets have been applied by surgeons to gain exposure, dissect tissue planes, achieve hemostasis, and recently, to create an anastomosis a central feature of many gastrointestinal, thoracic, biliary, colorectal, urological, and vascular procedures. GT has developed novel incisionless technology that employs magnetic compression to tunnel and heal an anastomosis, obviating the need for sutures, staples, clips, and glue.
To learn more about GT Metabolic Solutions, visit https://gtmetabolic.com/
Contact:
Thierry Thaure, Chief Executive Officer
626-793-7134
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.